As presented, the visualized images substantiated clearly different intensity levels for the Iba‐1+, CD86+/Iba‐1+, and CD206+/Iba‐1+ cells in the stroke/control groups compared to the sham/control groups. The gene discussed is CD86; the disease is stroke disorder.